Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 13 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-3.93 Insider Own19.91% Shs Outstand38.38M Perf Week10.23%
Market Cap326.61M Forward P/E- EPS next Y-2.71 Insider Trans129.39% Shs Float30.74M Perf Month-14.56%
Income-90.25M PEG- EPS next Q-0.64 Inst Own78.12% Short Float2.73% Perf Quarter-30.70%
Sales0.00M P/S- EPS this Y44.59% Inst Trans-0.60% Short Ratio3.38 Perf Half Y111.17%
Book/sh5.57 P/B1.53 EPS next Y-1.22% ROA-37.74% Short Interest0.84M Perf Year37.70%
Cash/sh5.37 P/C1.58 EPS next 5Y- ROE-45.75% 52W Range1.81 - 15.05 Perf YTD38.60%
Dividend Est.- P/FCF- EPS past 5Y32.21% ROI-38.51% 52W High-43.46% Beta1.89
Dividend TTM- Quick Ratio14.94 Sales past 5Y-28.11% Gross Margin55.00% 52W Low370.17% ATR (14)0.63
Dividend Ex-Date- Current Ratio14.94 EPS Y/Y TTM52.93% Oper. Margin0.00% RSI (14)50.24 Volatility8.24% 6.98%
Employees88 Debt/Eq0.12 Sales Y/Y TTM-100.00% Profit Margin- Recom1.56 Target Price15.57
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q58.55% Payout- Rel Volume0.96 Prev Close7.93
Sales Surprise- EPS Surprise2.91% Sales Q/Q- EarningsMar 13 BMO Avg Volume248.44K Price8.51
SMA204.10% SMA50-8.84% SMA20027.14% Trades Volume238,774 Change7.31%
Date Action Analyst Rating Change Price Target Change
May-31-24Resumed Piper Sandler Overweight $20
Mar-28-24Initiated William Blair Outperform $40
Mar-15-24Initiated Citigroup Buy $16
Mar-14-24Upgrade Piper Sandler Neutral → Overweight $8 → $20
Dec-08-23Initiated H.C. Wainwright Buy $9
Jul-12-21Initiated Piper Sandler Neutral $6
May-27-21Initiated Jefferies Buy $7
Mar-16-21Upgrade SVB Leerink Mkt Perform → Outperform $3 → $15
Mar-09-21Initiated Barclays Overweight $13
Jan-08-21Upgrade Credit Suisse Underperform → Neutral $2 → $7
Jun-04-24 04:00PM
May-20-24 06:00AM
May-15-24 12:53PM
May-07-24 07:00AM
04:05PM Loading…
May-02-24 04:05PM
Apr-03-24 04:05PM
Apr-02-24 10:35AM
Apr-01-24 07:45AM
Mar-28-24 04:08PM
Mar-27-24 07:00AM
Mar-13-24 07:44AM
Mar-07-24 07:00AM
Mar-06-24 08:00AM
03:02AM Loading…
Feb-29-24 03:02AM
Jan-17-24 11:27AM
Jan-16-24 01:10PM
Jan-15-24 10:18AM
Jan-08-24 07:09AM
Jan-04-24 08:00AM
Dec-08-23 05:37AM
Dec-07-23 08:00AM
Nov-22-23 08:00AM
Nov-16-23 08:29AM
Nov-14-23 04:05PM
Nov-09-23 08:00AM
Nov-08-23 04:17PM
Oct-02-23 08:00AM
08:00AM Loading…
Sep-20-23 08:00AM
Sep-05-23 08:56AM
Aug-31-23 08:00AM
Aug-14-23 04:17PM
Jun-01-23 08:00AM
May-22-23 08:00AM
May-16-23 08:00AM
May-11-23 09:35AM
May-08-23 04:05PM
Apr-21-23 08:00AM
Apr-20-23 10:03AM
Apr-19-23 10:01AM
Apr-13-23 08:00AM
Mar-25-23 09:44AM
Mar-23-23 08:00AM
Mar-21-23 08:00AM
Mar-07-23 08:00AM
Mar-02-23 07:52AM
Feb-08-23 08:00AM
Jan-26-23 08:00AM
Jan-11-23 08:00AM
Jan-10-23 08:00AM
Jan-09-23 04:26PM
Dec-05-22 04:35PM
Dec-01-22 04:15PM
Nov-22-22 08:00AM
Nov-10-22 08:55AM
Nov-08-22 06:25PM
Nov-01-22 07:55AM
Oct-27-22 10:02AM
Oct-26-22 10:02AM
Oct-20-22 02:41PM
Oct-17-22 11:30AM
Oct-13-22 08:00AM
Oct-03-22 05:32AM
Sep-30-22 07:00AM
Sep-29-22 08:00AM
Aug-14-22 08:07AM
Aug-13-22 08:06AM
Aug-11-22 09:15AM
Jul-14-22 08:13AM
Jun-23-22 08:00AM
Jun-02-22 08:30AM
May-17-22 08:00AM
May-02-22 09:29AM
Apr-28-22 01:38PM
Apr-27-22 10:35AM
Apr-25-22 08:00AM
Apr-07-22 08:23AM
Apr-05-22 02:20PM
Apr-04-22 10:40AM
Mar-14-22 09:35AM
Feb-10-22 08:00AM
Feb-04-22 10:14AM
Jan-10-22 08:00AM
Jan-06-22 08:00AM
Jan-05-22 12:00PM
Jan-04-22 08:00AM
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kahn ClareDirectorJun 07 '24Buy7.671,1008,4421,100Jun 11 02:15 PM
Ganot IlanDirectorMay 02 '24Sale10.334624,7729,507May 06 06:48 PM
Ganot IlanDirectorJan 29 '24Sale7.991391,1118,416Jan 30 05:20 PM
PERCEPTIVE ADVISORS LLCDirectorJan 11 '24Buy5.533,410,71318,861,2436,833,539Jan 12 05:15 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJan 11 '24Buy5.53904,1605,000,0054,192,216Jan 12 05:01 PM
Tan KevinCFO & TreasurerJan 09 '24Sale8.203,93532,2679,308Jan 11 05:43 PM
Ganot IlanDirectorJan 03 '24Sale5.301,1426,0528,167Jan 05 07:04 PM
Cumbo AlexanderPresident and CEODec 04 '23Sale2.7711,75732,51617,439Dec 05 02:40 PM
Howton David TChief Operating OfficerDec 04 '23Sale2.785,36714,9207,684Dec 05 02:32 PM
Hanrahan JessieChief Regulatory OfficerDec 04 '23Sale2.784,87913,5626,983Dec 05 02:30 PM
Marlowe JenniferCSODec 04 '23Sale2.774,89013,5256,998Dec 05 02:30 PM
Herzich PaulChief Technology OfficerDec 04 '23Sale2.772,9688,2324,270Dec 05 02:31 PM